- Home
- FENG vs CING Comparison
FENG vs CING Comparison
Compare FENG & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- CING
- Stock Information
- Founded
- FENG 1998
- CING 2012
- Country
- FENG China
- CING United States
- Employees
- FENG N/A
- CING N/A
- Industry
- FENG Broadcasting
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- FENG Industrials
- CING Health Care
- Exchange
- FENG Nasdaq
- CING Nasdaq
- Market Cap
- FENG 26.8M
- CING 22.0M
- IPO Year
- FENG 2011
- CING 2021
- Fundamental
- Price
- FENG $2.66
- CING $3.70
- Analyst Decision
- FENG
- CING Strong Buy
- Analyst Count
- FENG 0
- CING 4
- Target Price
- FENG N/A
- CING $31.00
- AVG Volume (30 Days)
- FENG 19.2K
- CING 132.0K
- Earning Date
- FENG 11-11-2025
- CING 11-06-2025
- Dividend Yield
- FENG N/A
- CING N/A
- EPS Growth
- FENG N/A
- CING N/A
- EPS
- FENG N/A
- CING N/A
- Revenue
- FENG $101,168,374.00
- CING N/A
- Revenue This Year
- FENG N/A
- CING N/A
- Revenue Next Year
- FENG N/A
- CING N/A
- P/E Ratio
- FENG N/A
- CING N/A
- Revenue Growth
- FENG 5.53
- CING N/A
- 52 Week Low
- FENG $1.28
- CING $3.02
- 52 Week High
- FENG $3.49
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- FENG 59.09
- CING 39.94
- Support Level
- FENG $2.51
- CING $3.70
- Resistance Level
- FENG $2.68
- CING $4.00
- Average True Range (ATR)
- FENG 0.22
- CING 0.23
- MACD
- FENG 0.01
- CING 0.02
- Stochastic Oscillator
- FENG 55.17
- CING 15.27
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.